Long-Term Efficacy of a Hepatitis E Vaccine
- 5 March 2015
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 372 (10), 914-922
- https://doi.org/10.1056/nejmoa1406011
Abstract
Hepatitis E virus (HEV) is a leading cause of acute hepatitis. The long-term efficacy of a hepatitis E vaccine needs to be determined.Keywords
This publication has 24 references indexed in Scilit:
- Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunityClinical Microbiology & Infection, 2014
- Epidemiology of Zoonotic Hepatitis E: A Community-Based Surveillance Study in a Rural Population in ChinaPLOS ONE, 2014
- Host Immune Status and Response to Hepatitis E Virus InfectionClinical Microbiology Reviews, 2014
- Hepatitis E virus infection: Multiple faces of an underestimated problemJournal of Hepatology, 2013
- Epidemiology of Hepatitis E in Low- and Middle-Income Countries of Asia and AfricaSeminars in Liver Disease, 2013
- Hepatitis EThe New England Journal of Medicine, 2012
- Hepatitis EThe Lancet, 2012
- The global burden of hepatitis E virus genotypes 1 and 2 in 2005Journal of Hepatology, 2012
- Hepatitis E Epidemic, UgandaEmerging Infectious Diseases, 2010
- Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-1987JAMA, 1990